APA (7th ed.) Citation

HY, C., CJ, C., TH, H., SY, T., FN, C., MK, S., & SH, J. (2026). Simvastatin enhances the antitumor activity of temsirolimus through AMPK-associated metabolic modulation in clear-cell renal cell carcinoma. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05733-8

Chicago Style (17th ed.) Citation

HY, Chen, Cheng CJ, Hsu TH, Tung SY, Chou FN, Satapathy MK, and Juan SH. "Simvastatin Enhances the Antitumor Activity of Temsirolimus Through AMPK-associated Metabolic Modulation in Clear-cell Renal Cell Carcinoma." Naunyn-Schmiedeberg's Archives of Pharmacology 2026. https://doi.org/10.1007/s00210-026-05733-8.

MLA (9th ed.) Citation

HY, Chen, et al. "Simvastatin Enhances the Antitumor Activity of Temsirolimus Through AMPK-associated Metabolic Modulation in Clear-cell Renal Cell Carcinoma." Naunyn-Schmiedeberg's Archives of Pharmacology, 2026, https://doi.org/10.1007/s00210-026-05733-8.